We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-12.47%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$88.7M
AUM Growth
+$635K
Cap. Flow
+$15.4M
Cap. Flow %
17.33%
Top 10 Hldgs %
88.06%
Holding
43
New
12
Increased
20
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
+$13.5M
2
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$2.23M
3
ABDC
Alcentra Capital Corp
ABDC
+$1.39M
4
CLMT icon
Calumet Specialty Products
CLMT
+$281K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$237K

Top Sells

Rank Stock Value
1
AMLP icon
Alerian MLP ETF
AMLP
+$4.53M
2
LITS
Lite Strategy Inc
LITS
+$2.29M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$244K
4
MRKR icon
Marker Therapeutics
MRKR
+$189K
5
KALA icon
KALA BIO
KALA
+$97.4K

Sector Composition

Rank Sector Weight
1 Healthcare 63.92%
2 Financials 4.56%
3 Consumer Discretionary 1.07%
4 Industrials 1.06%
5 Communication Services 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
$15.8M 17.82%
6,612,065
– –
STSA
2
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$13.1M 14.74%
+870,820
New +$13.5M
MTEM
3
DELISTED
Molecular Templates, Inc.
MTEM
$10.7M 12.07%
108,283
– –
ABDC
4
DELISTED
Alcentra Capital Corp
ABDC
$8.89M 10.02%
1,000,000
+161,160
+19% +$1.39M
GARS
5
DELISTED
Garrison Capital Inc.
GARS
$8.45M 9.53%
1,223,096
– –
KALA icon
6
KALA BIO
KALA
$15.7M
$5.64M 6.36%
594
-8
-1% -$97.4K
SCYX icon
7
SCYNEXIS
SCYX
$44.5M
$4.61M 5.19%
54,063
– –
SPY icon
8
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$4.16M 4.69%
14,010
– –
VIRX
9
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.85M 4.34%
152,738
+77,143
+102% +$2.23M
SPY icon
10
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$2.92M 3.29%
+9,836
New +$2.91M
BRK.B icon
11
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.94M 2.18%
9,312
– –
LITS
12
Lite Strategy Inc
LITS
$33M
$1.42M 1.6%
42,278
-62,799
-60% -$2.29M
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$636K 0.72%
2,067
+4
+0.2% +$1.3K
KURA icon
14
Kura Oncology
KURA
$967M
$479K 0.54%
31,567
+4,165
+15% +$74.1K
FSK icon
15
FS KKR Capital
FSK
$3.11B
$468K 0.53%
20,070
+9,933
+98% +$233K
MELI icon
16
Mercado Libre
MELI
$94.2B
$274K 0.31%
496
+39
+9% +$23.6K
CTIC
17
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$272K 0.31%
325,185
+733
+0.2% +$559
TDG icon
18
TransDigm Group
TDG
$68.9B
$269K 0.3%
516
+37
+8% +$19K
AMT icon
19
American Tower
AMT
$78.7B
$268K 0.3%
1,210
+74
+7% +$16.2K
CHTR icon
20
Charter Communications
CHTR
$16.4B
$262K 0.3%
635
+44
+7% +$17.8K
GB
21
DELISTED
Global Blue Group Holding
GB
$261K 0.29%
25,553
+44
+0.2% +$451
MA icon
22
Mastercard
MA
$487B
$260K 0.29%
956
+64
+7% +$17.6K
V icon
23
Visa
V
$694B
$252K 0.28%
1,465
+95
+7% +$16.9K
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$4.33T
$244K 0.28%
+4,000
New +$237K
UAL icon
25
United Airlines
UAL
$38.6B
$244K 0.28%
2,763
+197
+8% +$17.4K
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q3 2019 Portfolio in Review

As of Q3 2019, Caxton Corporation held 43 positions worth $88.7M, up 0.72% from $88M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Caxton Corporation deployed $15.4M of net new capital in Q3 2019, opening 12 new positions and adding to 20 existing holdings. Its largest new stake was Satsuma Pharmaceuticals, Inc. Common Stock: 870,820 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 66% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Lite Strategy Inc, an estimated $2.29M trimmed.

  • Caxton Corporation's largest Q3 2019 buy was Satsuma Pharmaceuticals, Inc. Common Stock: 870,820 shares worth $13.1M.
  • Caxton Corporation added most to Viracta Therapeutics, Inc. Common Stock in Q3 2019, an estimated $2.23M increase.
  • Caxton Corporation's biggest Q3 2019 reduction was Lite Strategy Inc, cutting an estimated $2.29M.
  • Caxton Corporation fully exited Alerian MLP ETF in Q3 2019, selling an estimated $4.53M.
  • Caxton Corporation's ten largest holdings make up 88% of its $88.7M portfolio in Q3 2019.
  • Caxton Corporation opened 12 new positions and closed 3 in Q3 2019.
  • Caxton Corporation's portfolio value rose 0.72% quarter-over-quarter to $88.7M.

Based on Caxton Corporation's 13F filing for Q3 2019, filed 14 Nov 2019.